The Financial Times reported on Thursday that Keep, a Chinese sports-oriented social platform, and Ximalaya, the largest podcast platform in China, have both cancelled previous IPO plans in the United States during recent weeks. exchanges if they do not comply with U.S. In 2016, LinkDoc had closed $10 million in a Series B round of financing from a group of healthcare-focused capital firms namely Ally Bridge Group, CBC Capital, and US New Enterprise Associates (NEA).On the same day, Reuters reported that LinkDoc, a Chinese medical technology company, had also shelved its IPO plan. “We expect to build sustainable partnerships with industries to expedite the digitalisation of the Chinese healthcare sector, facilitate commercialisation for severe diseases, and develop AI- and big data-oriented healthcare infrastructure,” it said in the statement.
Its services are used in hospitals, clinics, pharmaceutical companies and government administrations, which include Chinese Medical Doctor Association, and China Society of Clinical Oncology, among others. The developer offers a repository of big data for the healthcare industry such as clinical trial, AI diagnosis and management.
Since its inception in 2014, in Beijing, LinkDoc has engaged in cloud-based medical information systems and software. LinkDoc had completed a 1 billion yuan ($143 million) Series D round exclusively from state-owned China Investment Corporation in July 2018. With the latest round of funding, LinkDoc will continue to spruce up its big data service platforms and tools, the company said. The fresh round also witnessed participation from new investors namely CICC Capital, Youshan Capital and iFOF, a fund of funds of the private equity firm CBC Capital. Expands Ban on Sales of Chipmaking Gear to China China Semiconductor Fund Graft Scandal Widens as Another Executive Probed, Sources Say Chinese Online Grocer Missfresh Shutters Core Business After Failing to Secure a Lifeline Nasdaq-Traded Kingsoft Cloud Files for Dual Primary Listing in Hong KongĬhina Investment Corporation-backed LinkDoc Technology (Beijing) Company Limited, a provider of medical data solutions and oncology big data services, has raised 700 million yuan ($102 million) in a Series D+ round from undisclosed existing investors, LinkDoc announced on WeChat on Monday. Expands Export Sanction to Seven More Chinese Tech Firms Narrower Second-Quarter Losses Fail to Cheer Kuaishou Investors JD.com Posts Fivefold Profit Jump Even as Revenue Growth Slows Embattled EV-Maker Faraday Future’s Losses Widen Slowing Growth in Sea’s Gaming and E-Commerce Business Clobbers Its Bottom Line SAIC-Backed Xiangdao Raises $148 Million and Eyes IPO Analysis: How Will Biden’s CHIPS Bill Alter the Global Landscape? Kuaishou Dives Into Cloud Services and Chipmaking China’s Tsingshan Looms Over Tesla’s $5 Billion in Indonesian Nickel Deals Kuaishou Sets Up New Management Committee, a Year After Massive Restructuring Vivo Becomes Latest Chinese Smartphone-Maker Accused of Tax Evasion in India Retailer Gome Upends E-Commerce Unit, Fires Staff China Rolls Out Short-Message BeiDou Chip for Smartphones China’s Game Approval List Again Leaves Out Tencent and NetEase U.S. LATEST U.S., Europe Expected to Take Bigger Bite of Global Power Battery Production by 2026 China Charts Course for Self-Flying Cars U.S.
0 kommentar(er)
